Zhen‐Wei Cai

1.8k total citations
14 papers, 339 citations indexed

About

Zhen‐Wei Cai is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Zhen‐Wei Cai has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Zhen‐Wei Cai's work include Angiogenesis and VEGF in Cancer (5 papers), Catalytic Cross-Coupling Reactions (2 papers) and Fibroblast Growth Factor Research (2 papers). Zhen‐Wei Cai is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Catalytic Cross-Coupling Reactions (2 papers) and Fibroblast Growth Factor Research (2 papers). Zhen‐Wei Cai collaborates with scholars based in United States, Sweden and Italy. Zhen‐Wei Cai's co-authors include George Sosnovsky, Joseph E. Rice, Joseph Fargnoli, Louis J. Lombardo, John T. Hunt, R. M. Borzilleri, Barri Wautlet, Rajeev S. Bhide, John S. Tokarski and Robert Jeyaseelan and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Zhen‐Wei Cai

14 papers receiving 331 citations

Peers

Countries citing papers authored by Zhen‐Wei Cai

Since Specialization

Citations

This map shows the geographic impact of Zhen‐Wei Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Wei Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Wei Cai more than expected).

Fields of papers citing papers by Zhen‐Wei Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen‐Wei Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Wei Cai. The network helps show where Zhen‐Wei Cai may publish in the future.

Co-authorship network of co-authors of Zhen‐Wei Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen‐Wei Cai. A scholar is included among the top collaborators of Zhen‐Wei Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen‐Wei Cai. Zhen‐Wei Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Gretchen M. Schroeder, Donna Wei, Patrizia Banfi, Zhen‐Wei Cai, Jonathan Lippy, Maria Menichincheri, (unknown), Joseph G. Naglich, Becky Penhallow, Heidi L. Perez, John S. Sack, Robert J. Schmidt, Andrew J. Tebben, Chunhong Yan, Liping Zhang, Arturo Galvani, Louis J. Lombardo, R. M. Borzilleri	18
2	Design, synthesis and structure–activity relationships of novel biarylamine-based Met kinase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·David Williams, Xiaotao Chen, Christine M. Tarby, Robert F. Kaltenbach, Zhen‐Wei Cai, John S. Tokarski, Yongmi An, John S. Sack, Barri Wautlet, Johnni Gullo-Brown, Benjamin J. Henley, Robert Jeyaseelan, Kristen A. Kellar, Veeraswamy Manne, George L. Trainor, Louis J. Lombardo, Joseph Fargnoli, R. M. Borzilleri	16
3	The Antiangiogenic Activity in Xenograft Models of Brivanib, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinases 2010 ·Molecular Cancer Therapeutics ·Rajeev S. Bhide, Louis J. Lombardo, John T. Hunt, Zhen‐Wei Cai, Joel C. Barrish, Susan Galbraith, Robert Jeyaseelan, Steven Mortillo, Barri Wautlet, Bala Krishnan, Daniel Kukral, (unknown), Anne Lewin, Benjamin J. Henley, Joseph Fargnoli	52
4	Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Zhen‐Wei Cai, Donna Wei, R. M. Borzilleri, Ligang Qian, Amrita V. Kamath, Steven Mortillo, Barri Wautlet, Benjamin J. Henley, Robert Jeyaseelan, John S. Tokarski, John T. Hunt, Rajeev S. Bhide, Joseph Fargnoli, Louis J. Lombardo	21
5	Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Zhen‐Wei Cai, Donna Wei, Gretchen M. Schroeder, Lyndon A. M. Cornelius, Kyoung Kim, Xiaotao Chen, Robert J. Schmidt, David Williams, John S. Tokarski, Yongmi An, John S. Sack, Veeraswamy Manne, Amrita V. Kamath, Yueping Zhang, Punit Marathe, John T. Hunt, Louis J. Lombardo, Joseph Fargnoli, R. M. Borzilleri	51
6	Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·R. M. Borzilleri, Zhen‐Wei Cai, Christopher D. Ellis, Joseph Fargnoli, Aberra Fura, (unknown), Bindu Goyal, John T. Hunt, Steven Mortillo, Ligang Qian, John S. Tokarski, Viral Vyas, Barri Wautlet, (unknown), Rajeev S. Bhide	24
7	Preclinical studies of BMS-582664, an alanine prodrug of BMS-540215, a potent, dual inhibitor of VEGFR-2 and FGFR-1 kinases 2005 ·Joseph Fargnoli, Rajeev S. Bhide, Louis J. Lombardo, John T. Hunt, Zhen‐Wei Cai, Joel C. Barrish, Susan Galbraith, Robert Jeyaseelan, (unknown), (unknown), Barri Wautlet, Bala Krishnan, Anne Lewin, Benjamin J. Henley	1
8	Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors 2005 ·Journal of Medicinal Chemistry ·R. M. Borzilleri, Xiaoping Zheng, Ligang Qian, Christopher D. Ellis, Zhen‐Wei Cai, Barri Wautlet, (unknown), Robert Jeyaseelan, Daniel Kukral, Aberra Fura, Amrita V. Kamath, Viral Vyas, John S. Tokarski, Joel C. Barrish, John T. Hunt, Louis J. Lombardo, Joseph Fargnoli, Rajeev S. Bhide	49
9	Addition of Benzylic and Allylic Organozinc and Grignard Reagents to Resin-Bound Imines To Provide α-Branched Secondary Amines Bearing a Wide Variety of Functional Groups. Utility in the Synthesis of β-3 Adrenergic Receptor Agonists 2004 ·Journal of Combinatorial Chemistry ·Gang Wu, Zhen‐Wei Cai, Mark S. Bednarz, Octavian Kocy, Ashvinikumar V. Gavai, Jollie D. Godfrey, William N. Washburn, Michael A. Poss, Philip M. Sher	3
10	Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels: Direct Labeling Using a Novel Fluorescent Diltiazem Analog 1995 ·Biochemistry ·(unknown), Zhen‐Wei Cai, S. David Kimball, (unknown), Richard P. Haugland, Walter Berger, (unknown), Steffen Hering, Hartmut Glossmann, Jörg Striessnig	8
11	A Study of the Favorskii Rearrangement with 3-Bromo-4-oxo-2,2,6,6-tetramethylpiperidine-1-oxyl 1995 ·The Journal of Organic Chemistry ·George Sosnovsky, Zhen‐Wei Cai	41
12	Some Observations on the Palladium-Catalyzed Triflate-Arene Cyclization of Electron-Rich Biaryl Substrates 1995 ·The Journal of Organic Chemistry ·Joseph E. Rice, Zhen‐Wei Cai, (unknown), Edmond J. LaVoie	28
13	Evaluation of the tumor-initiating activity of 4-, 5-, 6-, and 7-fluorobenzo[b]fluoranthene in mouse skin 1993 ·Chemico-Biological Interactions ·Edmond J. LaVoie, Zhen‐Wei Cai, Rupalie L. Meegalla, Eric H. Weyand	1
14	A palladium-catalyzed intramolecular arene-triflate coupling for the synthesis of fluoranthenes and benzofluoranthenes 1992 ·Tetrahedron Letters ·Joseph E. Rice, Zhen‐Wei Cai	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact